AI assistant
SOBR Safe, Inc. — Director's Dealing 2020
Jan 16, 2020
35413_dirs_2020-01-16_c08791bd-a2f6-4fb5-8e09-f1fe11a2a870.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransBiotec, Inc. (IMLE)
CIK: 0001425627
Period of Report: 2019-10-31
Reporting Person: Moore Kevin D (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-31 | Common Stock | A | 800000 | — | Acquired | 800000 | Direct |
| 2019-11-30 | Common Stock | A | 800000 | — | Acquired | 1600000 | Direct |
| 2019-12-31 | Common Stock | A | 800000 | — | Acquired | 2400000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-22 | Common Stock Option | $0.0079 | A | 35200000 | Acquired | 2029-12-22 | Common Stock (35200000) | Direct |
Footnotes
F1: Under the terms of the Reporting Person's Employment Agreement as the Issuer's Chief Executive Officer, he is entitled to 800,000 shares of the Issuer's common stock on each of October 31, 2019, November 30, 2019 and December 31, 2019.
F2: Pursuant to the Reporting Person's Employment Agreement, he was issued a stock option to acquire 35,200,000 shares of the Issuer's common stock at $0.00792 per share. The shares vest in equal monthly installments of 977,777 shares per month for 36 months and expire ten years from the vesting date.